Events

In this UCSF Department of Medicine Covid Grand Rounds, we’ll begin with a discussion of the new vaccine candidates. Just in the past few weeks, we’ve seen new data regarding several vaccines, including J&J, AstraZeneca, and Novavax. Dr. Monica Gandhi will review these new data, and discuss the implications for vaccine supply – and why it’s appropriate to be optimistic about vaccines, even in the face of a sluggish roll-out and the threat of variants. She’ll add a few thoughts about whether vaccinated people can change behavior. Dr.

Special presentation and feedback session with NIAID's Peter Kim, Director of the Therapeutics Research Program in the Division of AIDS.

Questions include: What did we learn from the COVID response about NIAID-funded research (HIV, TB, emerging infectious diseases)? How should allocations be changed and pandemic responses optimized? What have we learned about HIV setbacks caused by COVID, and how should we fix them?

The UCSF CFAR Substance Use Program of Research (SUPR) and the Biomarkers of Behavior Sub-Core are hosting a networking lunch and featuring two speakers focused on substance use and HIV on January 18 from 12:30 - 3:30PM PT

Please join us!

Natalie Crawford, PhD 
Associate Professor in Behavioral, Social and Health Education Sciences 
Rollins School of Public Health, Emory University 
Co-Director, Prevention and Implementation Sciences Core, Emory CFAR

Wayne and Gladys Valley Tower 
490 Illinois St. Topaz Rm (1st floor) 
UCSF Mission Bay Campus